Filing Flows › Co-Diagnostics (CODX) › Next earnings date
Co-Diagnostics (CODX) earnings on Nov 10, 2026: what to expect
Co-Diagnostics (CODX) is expected to report earnings on Nov 10, 2026, in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$1.25 (1 estimate) on revenue of $169K, against −$4.66 and $145K a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 71% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$4.66 on revenue of $292K, against the analysts' −$1.25.
The last report
Co-Diagnostics reported revenue of $166K for the second quarter 2026 (+2% Y/Y), net loss $6.3M. How it makes money → · Every quarter →
Co-Diagnostics' latest quarter
Co-Diagnostics, Q2 2026: revenue $166K (+2% year over year), net loss $6.3M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.
Questions
When does CODX report earnings?
Co-Diagnostics is expected to report on Nov 10, 2026.
What are analysts expecting from Co-Diagnostics?
EPS of −$1.25 and revenue of $169K for the quarter.
Does Co-Diagnostics usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.